Skip to main content
. Author manuscript; available in PMC: 2015 Jun 16.
Published in final edited form as: Curr Pharm Biotechnol. 2011 Sep;12(9):1455–1462. doi: 10.2174/138920111798281027

Figure 5. Simvastatin pretreatment ameliorates lung cellular inflammatory response to infection.

Figure 5

A. Bronchoalveolar fluid (BALF) obtained 24 h post challenge was assessed for differential cell counts. B. Myeloperoxidase (MPO) activity was assessed in BALF as described in Methods. *p≤0.05. U=Uninfected mice, I=Infected mice. n= 5 mice per group.